Corballis, N.; Bhalraam, U.; Merinopoulos, I.; Gunawardena, T.; Tsampasian, V.; Wickramarachchi, U.; Eccleshall, S.; Vassiliou, V.S.
One-Month Duration Compared with Twelve-Month Duration of Dual Antiplatelet Therapy in Elective Angioplasty for Coronary Artery Disease: Bleeding and Ischaemic Outcomes. J. Clin. Med. 2024, 13, 4521.
https://doi.org/10.3390/jcm13154521
AMA Style
Corballis N, Bhalraam U, Merinopoulos I, Gunawardena T, Tsampasian V, Wickramarachchi U, Eccleshall S, Vassiliou VS.
One-Month Duration Compared with Twelve-Month Duration of Dual Antiplatelet Therapy in Elective Angioplasty for Coronary Artery Disease: Bleeding and Ischaemic Outcomes. Journal of Clinical Medicine. 2024; 13(15):4521.
https://doi.org/10.3390/jcm13154521
Chicago/Turabian Style
Corballis, Natasha, U. Bhalraam, Ioannis Merinopoulos, Tharusha Gunawardena, Vasiliki Tsampasian, Upul Wickramarachchi, Simon Eccleshall, and Vassilios S. Vassiliou.
2024. "One-Month Duration Compared with Twelve-Month Duration of Dual Antiplatelet Therapy in Elective Angioplasty for Coronary Artery Disease: Bleeding and Ischaemic Outcomes" Journal of Clinical Medicine 13, no. 15: 4521.
https://doi.org/10.3390/jcm13154521
APA Style
Corballis, N., Bhalraam, U., Merinopoulos, I., Gunawardena, T., Tsampasian, V., Wickramarachchi, U., Eccleshall, S., & Vassiliou, V. S.
(2024). One-Month Duration Compared with Twelve-Month Duration of Dual Antiplatelet Therapy in Elective Angioplasty for Coronary Artery Disease: Bleeding and Ischaemic Outcomes. Journal of Clinical Medicine, 13(15), 4521.
https://doi.org/10.3390/jcm13154521
